On November 16m 2020 Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) constructs, reported participation in the following conferences during the month of November (Press release, Exicure, NOV 16, 2020, View Source [SID1234571160]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2020 Virtual Guggenheim Healthcare Talks | Idea Forum | Neuro/Immunology Day
One-on-one meetings
Monday, November 16, 2020
Virtual Fall Investor Summit
Presentation
Time: 4:00 PM Eastern Time
Location: Virtual Webcast, Available for Live Streaming
Monday, November 16, 2020
Replays of the webcast will be available on Exicure’s website for 30 days following the event.